Andy Mead

Enhanced Locomotor, Reinforcing, and Neurochemical Effects of Cocaine in Serotonin 5-Hydroxytryptamine 2C Receptor Mutant Mice

Beatriz Rocha, Evan H Goulding, Laura E. O’Dell et al. · Journal of Neuroscience · 2002 · 153 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

The α4β2 nicotinic acetylcholine-receptor partial agonist varenicline inhibits both nicotine self-administration following repeated dosing and reinstatement of nicotine seeking in rats

Eoin C. O’Connor, Dale Parker, Hans Rollema et al. · Psychopharmacology · 2009 · 120 citations

Medicine, Neuroscience, Pharmacology +12

Selective Disruption of Stimulus-Reward Learning in Glutamate Receptor<i>gria1</i>Knock-Out Mice

Andy Mead, David Stephens · Journal of Neuroscience · 2003 · 86 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

The Concordance between Nonclinical and Phase I Clinical Cardiovascular Assessment from a Cross-Company Data Sharing Initiative

Lorna Ewart, Mike Aylott, Mark Deurinck et al. · Toxicological Sciences · 2014 · 77 citations

Pharmacy, Pharmacology, Translational Sciences +17

Assessing the predictive value of the rodent neurofunctional assessment for commonly reported adverse events in phase I clinical trials

Andy Mead, Hamid Amouzadeh, Kathryn Chapman et al. · Regulatory Toxicology and Pharmacology · 2016 · 68 citations · Full text

Pharmacy, Neuroscience, Pharmacology +17